Acro Biomedical (ACBM) Accounts Payables (2015 - 2026)

Acro Biomedical has reported Accounts Payables for 12 years, with the latest figure at $63050.0 in Q2 2026.

• On a quarterly basis, Accounts Payables fell 33.97% year-over-year to $63050.0 in Q2 2026; TTM through Jun 2026 was $63050.0, a 33.97% decrease from a year earlier, with the FY2025 full-year figure at $55550.0, down 64.04% from the prior year.
• Accounts Payables was $63050.0 for Q2 2026 at Acro Biomedical, up from $55550.0 in the prior quarter.
• The five-year high for Accounts Payables was $155507.0 in Q3 2024, with the low at $15000.0 in Q2 2022.
• Average Accounts Payables over 5 years is $107757.7, with a median of $122184.0 recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Accounts Payables jumped 632.23% in 2023, then slumped 64.04% in 2025.
• Over 5 years, Accounts Payables stood at $76571.0 in 2022, then surged by 101.7% to $154444.0 in 2023, then grew by 0.01% to $154460.0 in 2024, then plunged by 64.04% to $55550.0 in 2025, then gained by 13.5% to $63050.0 in 2026.
• The last three Accounts Payables figures came in at $63050.0 (Q2 2026), $55550.0 (Q4 2025), and $116582.0 (Q3 2025), per Business Quant data.